Chorea associated with gabapentin use in an elderly man

https://doi.org/10.1016/j.amjopharm.2009.08.001Get rights and content

Abstract

Background: Chorea is a hyperkinetic movement disorder characterized by irregular, flowing, nonstereotyped, random, involuntary movements. Huntington disease (HD) and drug-induced chorea account for >50% of adult-onset cases. Chorea associated with gabapentin, an anticonvulsant, has not been well documented.

Objective: The purpose of this article was to report a case of chorea that developed in an elderly man being treated with gabapentin for severe anxiety.

Case summary: A 75-year-old white man (height, 165.1 cm; weight, 65.8 kg; body mass index, 19.6 kg/m2) with anxiety disorder not otherwise specified was admitted to a geriatric medicine psychiatric unit in Connecticut because of worsening symptoms of anxiety affecting his cognitive ability. On evaluation, the patient had choreiform movements involving the neck, trunk, upper and lower extremities, and tongue. The patient reported that symptoms began after taking gabapentin 300 mg PO TID (prescribed by his geriatrician) for the treatment of anxiety. The patient had been taking gabapentin for >1 month when the symptoms first appeared. There was no known family history of HD, and patient workup was unremarkable for other conditions (eg, vascular disease of the brain, progressive dementia, infectious and metabolic disorders) that might present with chorea. The chorea lasted for ~4 months and resolved within 2 days after gabapentin discontinuation.

Conclusion: This article reports a case of chorea in an elderly patient who was receiving gabapentin for the treatment of anxiety. After gabapentin discontinuation, the chorea resolved completely, indicating a probable adverse drug reaction.

References (12)

  • MT Lorincz

    Geriatric chorea

    Clin Geriatr Med.

    (2006)
    MT Lorincz

    Geriatric chorea

    Clin Geriatr Med.

    (2006)
  • P García Ruiz et al.

    Senile chorea: A multicenter prospective study

    Acta Neurol Scand.

    (1997)
  • H Shinotoh et al.

    Normal CAG repeat length in the Huntington's disease gene in senile chorea

    Neurology.

    (1994)
  • R Bhidayasiri et al.

    Chorea and related disorders [published correction appears in Postgrad Med J. 2004;80:649]

    Postgrad Med J.

    (2004)
  • CA Naranjo et al.

    A method for estimating the probability of adverse drug reactions

    Clin Pharmacol Ther.

    (1981)
  • JW Mink

    The basal ganglia and involuntary movements: Impaired inhibition of competing motor patterns

    Arch Neurol.

    (2003)
There are more references available in the full text version of this article.

Cited by (10)

  • Movement disorders associated with antiseizure medications: A systematic review

    2022, Epilepsy and Behavior
    Citation Excerpt :

    The gabapentin dose was reduced in 3 patients while drug was discontinued in all other cases. In addition, some patients with myoclonus underwent dialysis [295,315,316] or received haloperidol, diphenhydramine, lorazepam, or procyclidine [289,290,304,305]. In all instances, the interventions resulted in resolution of symptoms.

  • Gabapentinoids: A review of the literature

    2021, Toxicologie Analytique et Clinique
  • Pediatric Iatrogenic Movement Disorders

    2018, Seminars in Pediatric Neurology
    Citation Excerpt :

    Baclofen is another GABAergic medication that can induce chorea. The mechanism of induction of chorea with these medications is not precisely known, but hypotheses include the role of central dopaminergic pathways in the basal ganglia, drug-drug interactions in the setting of polypharmacy, and a possible genetic predisposition to movement disorders.10-18 Stimulant medications that are used in the treatment of ADHD are associated with induction of chorea.

  • Antiepileptic drugs

    2011, Side Effects of Drugs Annual
    Citation Excerpt :

    Gabapentin is excreted unchanged in the urine and its half-life, normally 5–9 hours, increases to up to 132 hours in anuria [114A]. Chorea in an elderly patient with anxiety resolved completely after gabapentin was withdrawn [115A]. A 75-year-old man with anxiety disorder developed choreiform movements involving the neck, trunk, upper and lower limbs, and tongue after taking gabapentin 300 mg three times a day (tds) for 1 month.

  • Diagnostic Uncertainties: Chorea

    2023, Seminars in Neurology
View all citing articles on Scopus
View full text